MYRIAD GENETICS INC — Director's Dealing 2013

May 17, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2013-05-16

Reporting Person: Capone Mark Christopher (President, MGL)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-05-16	Common Stock	M	60000	$18.06	Acquired	108268	Direct
2013-05-16	Common Stock	S	60000	$33.2318	Disposed	48268	Direct
2013-05-16	Common Stock	M	19999	$16.53	Acquired	68267	Direct
2013-05-16	Common Stock	S	19999	$33.2318	Disposed	48268	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-16	Non-Qualified Stock Option (right to buy)	$16.53	M	19999	Disposed	2020-09-15	Common Stock (19999)	Direct
2013-05-16	Non-Qualified Stock Option (right to buy)	$18.06	M	60000	Disposed	2017-09-26	Common Stock (60000)	Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.